–
Bicara Therapeutics Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.7
FY23:
−39.9
FY24:
−82.4
FY25:
−156
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.7
FY23:
−39.9
FY24:
−82.3
FY25:
−155
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.8
FY23:
−52.0
FY24:
−67.8
FY25:
−138
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.8
FY23:
−52.0
FY24:
−68.0
FY25:
−138
All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.